Rights Issue Raises $2.15 million
Filed with ASX · · 2 pages · English
Earlier from AnteoTech
- Heads of Agreement signed with Merck
- Rights Commence Trading
- Rights Issue Prospectus
- AnteoTech Granted Key US Battery Patent
- Response to ASXs Price Query
Later from AnteoTech
- R & D Refund Received
- AnteoTech and Axxin Build Successful Sepsis Multiplex Test
- AnteoTech Advances Battery Technology Program
- AnteoTech Developing Multiplex Test for COVID-19
- AnteoTech Secures $3.76M Option Underwriting Agreement
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech